Dual inhibitors of MET and VEGF for the treatment of castration resistant prostate cancer and osteoblastic bone metastases
- 专利权人:
- Inc.;Exelixis
- 发明人:
- Smith, David,Hussain, Maha
- 申请号：
- AU2011307309
- 公开号：
- AU2011307309A1
- 申请日:
- 2011.09.26
- 申请国别(地区):
- AU
- 年份:
- 2013
- 代理人:
- 摘要：
- This invention is directed to the treatment of cancer, particularly castration- resistant prostate cancer and osteoblastic bone metastases, with a dual inhibitor of MET and VEGF.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Dual inhibitors of MET and VEGF for the treatment of castration- resistant prostate cancer and osteoblastic bone metastases
- Dual inhibitors of MET and VEGF for the treatment of castration resistant prostate cancer and osteoblastic bone metastases
- DUAL INHIBITORS OF MET AND VEGF FOR THE TREATMENT OF CASTRATION- RESISTANT PROSTATE CANCER AND OSTEOBLASTIC BONE METASTASES
- DUAL INHIBITORS OF MET AND VEGF FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER AND OSTEOBLASTIC BONE METASTASES
- Dual inhibitors of MET and VEGF for the treatment of castration-resistant prostate cancer and osteoblastic bone metastases
